Default company panoramic image
Logo

CancerIQ

CancerIQ is a "GPS for cancer" that transforms information buried in publications and EMRs into insights needed to deliver precision care.

  • Stage Full Product Ready
  • Industry Healthcare Services
  • Location Chicago, IL, USA
  • Currency USD
  • Founded December 2012
  • Employees 8
  • Website cancer-iq.com

Company Summary

CancerIQ software uses clinical and genomics data to help providers build intelligence in cancer. We differentiate ourselves by providing a much higher resolution view of a patient than available in any EMR and by offering proprietary analytics to help interpret a growing number of variables. With CancerIQ, we use technology to manage the complexity of genomic medicine, and empower all oncologists to deliver premium personalized cancer care.

Team

  • Default avatar
    Feyi Olopade
    Ms.

    After years in banking and private equity, decided to apply finance skills for social good. Launched, managed, and ran the Wharton Social Venture Fund, the 1st student-run VC fund at Wharton. Has reviewed dozens of deals in education and healthcare, and co-invested with Investors' Circle, Acumen Fund, & New Schools Venture Fund. Left finance and took sabbatical from McKinsey for operating role at UChicago Medical Center, then spun off CancerIQ.

  • Default avatar
    Olufunmilayo Olopade
    Dr.

    Won a Macarthur "Genius" grant in 2005 for research on disparities in outcomes for breast cancer patients. The first to take a genetic based approach to understanding racial differences in survival, using data modeled by CancerIQ. Her evidence-based approach to medicine has broadened our understanding of the complex interactions of genes, lifestyle, and cancer causation. With this knowledge, she is leading expert on personalized cancer treatment.

  • Default avatar
    Paul Fung
    Mr.

  • Default avatar
    Haibo Lu
    Mr.

    After Harvard and a quant hedge fund, left analyst role to run the front office of the Shanghai Sharks, as the Director of Basketball Operations. Used Moneyball-style data analytics to inform personnel and strategy decisions, which helped the Sharks improve from 3rd to last in the league to 6th in 2 years. Leveraged this experience to lead basketball analytics for China’s Men’s National Basketball Team.

  • Default avatar
    Kisha Hope
    Ms.

Advisors

  • Default avatar
    Michael Esquivel, Fenwick & West
    Lawyer
    Unconfirmed